Mr. Mucus helps Reckitt dominate cough-and-cold space

What's the key to landing your brand on the leaderboard of cough-and-cold meds? Mr. Mucus, apparently. The Reckitt Benckiser spokes-character has propelled Mucinex to three of the top four slots on a new list of preferred OTC products, according to online data-analysis company Treato. More from FiercePharmaMarketing

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.